Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-05-22
2007-05-22
Li, Q. Janice (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S320100
Reexamination Certificate
active
10076900
ABSTRACT:
Methods of inducing mucosal immunity in individuals against proteins and peptides are disclosed. The methods comprise the step of administering topically or by lavage into mucosal tissue selected from the group consisting of rectal, vaginal, urethral, sublingual and buccal, a nucleic acid molecule that comprises a nucleotide sequence that encodes a protein or peptide that comprises an epitope against which mucosal immunity is desired. The methods may be used to immunize and individual against a pathogen infection, hyperproliferative diseases or autoimmune diseases using nucleic acid molecules which encode proteins and peptides that share an epitope with a pathogen antigen or protein associated with cells involved in hyperproliferative diseases or autoimmune diseases, respectively,
REFERENCES:
patent: 4224404 (1980-09-01), Viza et al.
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 5017487 (1991-05-01), Stunnenberg et al.
patent: 5036006 (1991-07-01), Sanford et al.
patent: 5185254 (1993-02-01), Linnenbach
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5593972 (1997-01-01), Weiner et al.
patent: 5679647 (1997-10-01), Carson et al.
patent: 5804566 (1998-09-01), Carson et al.
patent: 6214804 (2001-04-01), Felgner et al.
patent: 6348449 (2002-02-01), Weiner et al.
patent: WO 90/11092 (1990-10-01), None
patent: WO 91/12329 (1991-08-01), None
patent: WO 93/17706 (1993-09-01), None
patent: WO 93/23552 (1993-11-01), None
patent: WO 94/16737 (1994-08-01), None
patent: WO 94/17792 (1994-08-01), None
patent: WO 94/23738 (1994-10-01), None
patent: WO95/11701 (1995-05-01), None
patent: WO95/30019 (1995-11-01), None
patent: WO 96/14876 (1996-05-01), None
Wang et al, PNAS 1993;90:4156-60.
Gately et al, Cell Immunol 1992;143:127-42.
Sublingual: Merriam-Webster's Online dictionary, 2004.
Harris et al, J Pharm Sci 1992;81:1-10.
Acsadi et al., “Human Dystrophin Expression in Mdx Mice After Intramuscular Injection of DNA Constructs”,Nature 352: 815-818 (1991).
Anderson, W. French, “Prospects for Human Gene Therapy,”Science226:401-409, 1984.
Benoit et al., “Destruction and regeneration of skeletal muscle after treatment with a local anaesthetic, bupivacaine (Marcaine®),”J. Anat.107:547-556, 1970.
Benvenisty et al., “Direct introduction of genes into rats and expression of the genes,”Proc. Natl. Acad. Sci. USA, 83:9551-9555, 1986.
Brandsma et al., “Use of a rapid, efficient innoculation method to induce papillomas by conttontail rabbit papillomavirus DNA shows that the E7 gene is required,”Proc. Natl. Acad. Sci. USA, 88:4816-4820, 1991.
Brigham et al., “Rapid Communication: In Vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene Using A Liposome Vehicle,”American Journal of the Medical Sciences, 298:278-281, 1989.
Butini, L. et al., “Comparative Analysis of HIV-Specific CTL Activity in Lymphoid Tissue and Peripheral Blood” J. of Cell Biochem. Suppl 18B:147 (Abstract J306 (1994).
Dubensky et al., “Direct transfection of viral and plasmid DNA into the liver of spleen of mice,”Proc. Natl. Acad. Sci. USA, 81:7529-7533, 1984.
Felgner and Rhodes, “Gene Therapeutics”Nature 349: 351-352 (1991).
Fleckenstein et al., “Tumour induction with DNA of oncogenic primate herpesviruses,”Nature, 274:57-59, 1978.
Friedmann et al., “Progress Toward Human Gene Therapy,”Science, 244:1275-1281, 1989.
Hall-Craggs, E.C.B., “Rapid Degeneration and Regeneration of a Whole Skeletal Muscle Following Treatment with Bupivacain (Marcain),”Experimental Neurology, 43:349-358, 1974.
Haynes, B.F., “Scientific and Social Issues of Human Immunodeficiency Virus Vaccine Development” Science 260:1279-1286 (1993).
Howley, Peter M., “Papillomavirinae and Their Replication,”Virology, Chapter 58:1625-1650, 1990.
Israel et al., “Biological Activity of Polyoma Viral DNA in Mice and Hamsters,”J. of Virology, 29:990-996, 1979.
Kaneda et al., “Increased Expression of DNA Cointroduced with Nuclear Protein in Adult Rat Liver,”Science, 243:375-378, 1989.
Klein et al., “Transformation of Microbes, Plants and Animals by Particle Bombardment,”Bio/Technology, 10:286-291, 1992.
Knuth, A. et al., “Cellular and Humoral Immune Responses Against Cancer:Implications for Cancer Vaccines” Current Opinion in Immunology 3: 659-664 (1991).
Ledley, F.D., “Clinical Considerations in the Design of Protocols for Somatic Gene Therapy” Human Gene Therapy 2: 77-83 (1991).
Mayne et al., “Tumour Induction by Simian Adenovirus SA7 DNA Fragments,”Nature New Biology, 232:182-183, 1971.
McCutchan et al., “Enhancement of the Infectivity of Simian Virus 40 Deoxyribonucleic Acid with Diethylaminoethyl-Dextran,”J. of the Nat. Cancer Institute, 41:351-356, 1968.
Nabel et al., “Site-Specific Gene Expression in Vivo by Direct Gene Transfer into the Arterial Wall,”Science, 249:1285-1288, 1990.
Nicolau et al., “In vivo expression of rat insulin after intravenous administration of the lipsome-entrapped gene for rat insulin I,”Proc. Natl. Acad. Sci. USA, 80:1068-1072, 1983.
Orth et al., “Infectious and Oncogenic Effect of DNA Extracted from Cells Infected with Polyoma Virus,”P.S.E.B.M., 115:1090-1095, 1964.
Sol et al., “Oncogenicity of SV40 DNA in the Syrian Hamster,”J. gen. Vir.37:635-638, 1977.
Tang et al., “Genetic immunization is a simple method for eliciting an immune response,”Nature356:152-154, 1992.
Thomason et al., “Stable incorporation of a bacterial gene into adult rat skeletal muscle in vivo,”Cell Physiol., 27:C578-581, 1990.
Torpey, III, D. et al., “Effects of Adoptive Immunotherapy with Autologous CD8+T Lymphocytes on Immunologic Parameters: Lymphocyte Subsets and Cytotoxic Activity” Clinical Immunology and Immunopathology 68(3): 263-272 (1993).
Ulmer et al., “Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein,”Science, 259:1745-1749, 1993.
Vitadello et al., “Gene Transfer in Regenerating Muscle,”J. of Cellular Biochemistry, Suppl. 17E:252, Mar. 29-Apr. 25, 1993.
Wang, B. et al.,, “Gene Innoculation Generates Immune Responses Against Human Immundeficiency Virus Type 1” Proc. Natl. Acad. Sci. USA 90: 4156-4160 (1993).
Wells, D.J., “Improved Gene Transfer by Direct Plasmid Injection Associated with Regeneration in Mouse Skeletal Muscle” FEBS Letts 332(1,2) 179-182 (1993).
Will et al., “Cloned HBV DNA causes hepatitis in chimpanzees,”Nature, 299:740-742, 1982.
Wolff et al., “Direct Gene Transfer into Mouse Muscle in Vivo”Science 247: 1465-1468 (1990).
Wolff et al., “Conditions Affecting Direct Gene Transfer Into Rodent Muscle In Vivo”BioTechniques 11: 474-485 (1991).
Wu et al., “Receptor-mediated Gene Delivery and expression in Vivo,”J. of Biological Chemistry, 263:14621-14624, 1988.
Yang et al., “In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment,”Proc. Natl. Acad. Sci. USA, 87:9568-9572, 1990.
Zelenin et al., “High-velocity mechanical DNA transfer of the chloramphenicolacetyl transferase gene into rodent liver, kidney and mammary gland cells in organ explants and in vivo,”FEBS Letts., 280:94-96, 1991.
Fynan, E.F. et al., “Use of DNA encoding influenza Hemagglutinin as an avian influenza vaccine”,DNA Cell Biol., 1993, 12(9), 785-789.
Staats, H.F. et al., “Mucosal immunity to infection with implications for vaccine development”,Curr. Opin. Immunol., 1994, 6, 572-583.
Fynan, et al., “DNA vaccines: protective immunizations by parental, mucosal, and gene-gun inoculations,” Proc.
Ugen Kenneth E.
Wang Bin
Weiner David B.
Li Q. Janice
Pepper Hamilton LLP
The Trustees of the University of Pennsylvania
LandOfFree
Methods of inducing mucosal immunity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inducing mucosal immunity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inducing mucosal immunity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3758664